[ad_1] Eisai and Biogen announced that patients with early Alzheimer's disease who received the highest dose of experimental drug BAN2401 experienced a 30% decline in clinical decline compared to placebo at 18 …
Read More »Alzheimer's, experimental drug Eisai and Biogen slows down the decline
